Annual EBITDA
-$21.40 M
+$1.17 M+5.18%
December 31, 2023
Summary
- As of February 7, 2025, EVAX annual EBITDA is -$21.40 million, with the most recent change of +$1.17 million (+5.18%) on December 31, 2023.
- During the last 3 years, EVAX annual EBITDA has fallen by -$4.96 million (-30.18%).
- EVAX annual EBITDA is now -289.29% below its all-time high of -$5.50 million, reached on December 31, 2018.
Performance
EVAX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.65 M
+$4.53 M+73.31%
September 1, 2024
Summary
- As of February 7, 2025, EVAX quarterly EBITDA is -$1.65 million, with the most recent change of +$4.53 million (+73.31%) on September 1, 2024.
- Over the past year, EVAX quarterly EBITDA has increased by +$4.04 million (+71.05%).
- EVAX quarterly EBITDA is now -234.78% below its all-time high of $1.22 million, reached on March 31, 2024.
Performance
EVAX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.19 M
+$4.04 M+26.55%
September 1, 2024
Summary
- As of February 7, 2025, EVAX TTM EBITDA is -$11.19 million, with the most recent change of +$4.04 million (+26.55%) on September 1, 2024.
- Over the past year, EVAX TTM EBITDA has increased by +$13.46 million (+54.62%).
- EVAX TTM EBITDA is now -201.35% below its all-time high of -$3.71 million, reached on December 31, 2019.
Performance
EVAX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EVAX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.2% | +71.0% | +54.6% |
| 3 y3 years | -30.2% | +78.7% | +54.4% |
| 5 y5 years | -289.3% | +65.3% | +32.4% |
EVAX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.6% | -234.8% | +78.7% | at high | +57.4% |
| 5 y | 5-year | -99.7% | +11.6% | -234.8% | +78.7% | -201.3% | +57.4% |
| alltime | all time | -289.3% | +11.6% | -234.8% | +78.7% | -201.3% | +57.4% |
Evaxion Biotech A/S EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.65 M(-73.3%) | -$11.19 M(-26.5%) |
| Jun 2024 | - | -$6.17 M(-605.1%) | -$15.23 M(+3.3%) |
| Mar 2024 | - | $1.22 M(-126.6%) | -$14.74 M(-33.2%) |
| Dec 2023 | -$21.40 M(-5.2%) | -$4.59 M(-19.3%) | -$22.07 M(-10.4%) |
| Sep 2023 | - | -$5.69 M(+0.1%) | -$24.65 M(+1.3%) |
| Jun 2023 | - | -$5.69 M(-6.9%) | -$24.34 M(+4.1%) |
| Mar 2023 | - | -$6.11 M(-14.7%) | -$23.37 M(+1.0%) |
| Dec 2022 | -$22.57 M | -$7.17 M(+33.2%) | -$23.14 M(-2.4%) |
| Sep 2022 | - | -$5.38 M(+14.0%) | -$23.71 M(-1.0%) |
| Jun 2022 | - | -$4.72 M(-19.7%) | -$23.95 M(-8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$5.88 M(-23.9%) | -$26.23 M(+6.8%) |
| Dec 2021 | -$24.21 M(+47.2%) | -$7.73 M(+37.5%) | -$24.55 M(+13.8%) |
| Sep 2021 | - | -$5.62 M(-19.6%) | -$21.57 M(+5.1%) |
| Jun 2021 | - | -$6.99 M(+66.4%) | -$20.53 M(+17.5%) |
| Mar 2021 | - | -$4.20 M(-11.5%) | -$17.47 M(+5.6%) |
| Dec 2020 | -$16.44 M(+53.4%) | -$4.75 M(+3.6%) | -$16.55 M(+6.7%) |
| Sep 2020 | - | -$4.58 M(+16.5%) | -$15.51 M(+42.0%) |
| Jun 2020 | - | -$3.94 M(+20.2%) | -$10.92 M(+56.3%) |
| Mar 2020 | - | -$3.27 M(-11.8%) | -$6.99 M(+88.2%) |
| Dec 2019 | -$10.72 M(+94.9%) | -$3.71 M | -$3.71 M |
| Dec 2018 | -$5.50 M | - | - |
FAQ
- What is Evaxion Biotech A/S annual EBITDA?
- What is the all time high annual EBITDA for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S annual EBITDA year-on-year change?
- What is Evaxion Biotech A/S quarterly EBITDA?
- What is the all time high quarterly EBITDA for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S quarterly EBITDA year-on-year change?
- What is Evaxion Biotech A/S TTM EBITDA?
- What is the all time high TTM EBITDA for Evaxion Biotech A/S?
- What is Evaxion Biotech A/S TTM EBITDA year-on-year change?
What is Evaxion Biotech A/S annual EBITDA?
The current annual EBITDA of EVAX is -$21.40 M
What is the all time high annual EBITDA for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high annual EBITDA is -$5.50 M
What is Evaxion Biotech A/S annual EBITDA year-on-year change?
Over the past year, EVAX annual EBITDA has changed by +$1.17 M (+5.18%)
What is Evaxion Biotech A/S quarterly EBITDA?
The current quarterly EBITDA of EVAX is -$1.65 M
What is the all time high quarterly EBITDA for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high quarterly EBITDA is $1.22 M
What is Evaxion Biotech A/S quarterly EBITDA year-on-year change?
Over the past year, EVAX quarterly EBITDA has changed by +$4.04 M (+71.05%)
What is Evaxion Biotech A/S TTM EBITDA?
The current TTM EBITDA of EVAX is -$11.19 M
What is the all time high TTM EBITDA for Evaxion Biotech A/S?
Evaxion Biotech A/S all-time high TTM EBITDA is -$3.71 M
What is Evaxion Biotech A/S TTM EBITDA year-on-year change?
Over the past year, EVAX TTM EBITDA has changed by +$13.46 M (+54.62%)